This paper addresses the problem of power and sample size calculation for a stepwise multiple test procedure (SD2PC) proposed in Tamhane et al. [2001. Multiple test procedures for identifying the maximum safe dose. J. Amer. Statist. Assoc. 96,[835][836][837][838][839][840][841][842][843] to identify the maximum safe dose of a compound. A general expression for the power of this procedure is derived. It is used to find the minimum overall power and minimum power under the constraint that the dose response function is bounded from below by a linear response function. It is shown that the two minima are attained under step and linear response functions, respectively. The sample sizes necessary on the zero dose control and each of the positive doses to guarantee a specified power requirement are calculated under these two least favorable configurations. A technique involving a continuous approximation to the sample sizes is used to reduce the number of quantities that need to be tabled, and to derive the asymptotically optimal allocation of the total sample size between the zero dose and the positive doses. An example is given to illustrate use of the tables. Extensions of the basic formulation are noted.
Introduction
In Tamhane et al. (2001) (referred to as TDGW hereafter) we proposed three step-down (SD) multiple test procedures (labeled there as SD1PC, SD2PC and SD1HC) to find the maximum safe dose (MAXSD) of a compound in relation to a zero dose control. These procedures control the type I familywise error rate (FWE), which is the probability of declaring any unsafe dose as safe, at a specified level . In TDGW we investigated the power properties of the proposed procedures via simulation. In this paper we derive analytical expressions for the power of SD2PC (which is a preferred procedure for the reasons explained in the sequel). We use these expressions to calculate the sample sizes necessary to guarantee a specified power requirement.
Practical applications of the MAXSD approach were described in TDGW. This problem arises in toxicology experiments to evaluate safety of agricultural compounds where efficacy is not a concern. The MAXSD approach was motivated in the first author's collaborations with scientists from DuPont.
The outline of the paper is as follows. In Section 2, we define the notation and formulate the problem. The SD2PC procedure is briefly reviewed in Section 3. An expression for its power is derived in Section 4. This expression is used to find the minimum overall power and minimum power under the constraint that the dose response function is bounded from below by a linear response function. It is shown that the two minima are attained under step and linear response functions, respectively. The exact discrete optimization problem of finding the smallest total sample size under these two least favorable configurations to guarantee a specified power requirement is stated and solved in Section 5. A continuous approximation to this problem for the minimum overall power is stated and solved in Section 6. The solution from the continuous approximate problem is used as an initial solution for the numerical search of the corresponding exact discrete optimum. The continuous problem is also useful for deriving asymptotically optimal allocation of the sample sizes between the zero dose control and positive doses. An example is given in Section 7. Finally, some extensions of the basic formulation are noted in Section 8. An evaluation of the derivative of the power function needed in the continuous optimization problem is given in the Appendix.
Problem formulation
We assume the usual homoscedastic normal theory one-way layout model with increasing doses denoted by 0, 1, . . . , k, where 0 is the zero dose (control). The unknown dose means are denoted by i and the unknown common error variance by 2 . A smaller i (e.g., a lower yield of a crop contaminated by a herbicide) is assumed to represent a more toxic response. The case where a larger i represents a more toxic response can be handled analogously.
We take n i observations, y ij (1 j n i ), on dose i and compute the sample means y i and the pooled sample variance s 2 based on = k i=0 n i − (k + 1) degrees of freedom (df). The corresponding random variables Y i and S 2 are distributed independently as N( i , 2 /n i ) and 2 2 / , respectively. We regard a dose as unsafe if it causes a decrease in mean yield below a specified percentage (say, 10%) of the mean yield 0 at the zero dose level. More generally, we regard the ith dose as unsafe if i 0 and as safe if i > 0 where < 1 is specified, e.g., = 0.90 for a 10% decrease in the mean yield compared to 0 . The maximum safe dose (MAXSD) for specified is defined as
If a larger i represents a more toxic response then > 1. In that case, doses with i 0 are regarded as unsafe and those with i < 0 are regarded as safe. The MAXSD is defined as MAXSD = max{i : j < 0 ∀j i}. Note that the above definition assumes that 0 is > 0. This is a reasonable assumption in most practical problems as the measurements are positive. If necessary, a preliminary test could be performed to check it.
We want to guarantee that the probability that any unsafe dose is declared safe is no more than a specified constant . If MAXSD denotes the estimated MAXSD then this requirement translates to
Now consider the family of hypothesis testing problems
Here H 0i states that the ith dose is unsafe and H 1i states that the ith dose is safe. After testing the hypotheses we set MAXSD = max{i : H 0j is rejected ∀j i}. The error probability requirement (2.2) is satisfied if we control the type I FWE at level : Bauer (1997) .
In the present paper we restrict attention to the SD2PC procedure because (i) as noted above, it is valid even if the dose-response function is non-monotone, (ii) simulation studies reported in TDGW showed that SD2PC generally has high power, especially under the linear dose-response function, although its power can be very low under the step response function when the MAXSD is high, (iii) it is very easy to apply and explain to a practitioner, and (iv) it can be readily extended to non-normal setups, where statistics such as Mann-Whitney may be used for comparing each dose with the zero dose control.
Specification of the power requirement for the hypothesis testing problem (2.3) entails specification of two constants, (0 < < 1 − ) and 1 − ( < 1 − < 1). In analogy with definition (2.1) of MAXSD, we specify the power requirement as follows: P Reject all false H 0i with min
Under monotonicity, this is equivalent to a more stringent requirement in which min j i j is replaced by i . As an example, suppose = 0.90, = 0.05 and 1 − = 0.80. Then any dose with mean i > 0.90 0 is safe, but we want to guarantee that all consecutive doses with means i 0.95 0 are declared safe with probability at least 0.80. We note that Horn and Vollandt (2002) have done sample size calculations for a similar setting but for a formulation that uses an additive threshold constant in contrast to our multiplicative constant .
SD2PC procedure
The SD2PC procedure is a SD testing procedure based on pairwise contrasts, y i − y 0 (1 i k). The corresponding t-statistics are 
Power of SD2PC procedure
Suppose that i ( + ) 0 for 1 i m and i < ( + ) 0 for i > m, so that effectively m is the MAXSD as far as the power requirement (2.5) is concerned, which is then
To write the power expression, introduce the following notation:
Further let
2)
and U = S/ ∼ 2 / independent of the Z i 's. In other words, T i = Z i /U (1 i k) have a central k-variate t-distribution with the above correlation structure and df. Then, for fixed m (1 m k), the power expression (4.1) is given by
where
Then noting that the −Z i 's have the same joint distribution as the Z i 's, and by exploiting the product correlation structure in (4.2), we can express the m-variate normal probability in the last step of (4.3) as a univariate iterated integral (see Eq. (1.1a) in Appendix 3 of Hochberg and Tamhane (1987) ) leading to the following expression for power:
where (·) and (·) are, respectively, the c.d.f. and the p.d.f. of the standard normal distribution.
Minimum overall power
From symmetry considerations, we will assume that the experiment is designed with n 1 = n 2 = · · · = n k = n (say). Let n 0 /n = r. Suppose that the dose response function satisfies
Then, since (4.4) is increasing in the i , its minimum for fixed m (1 m k) is attained when
Thus the step response function is least favorable. Furthermore, the minimum over m is attained when m = k and it depends on and 0 / only through their product, denoted by = ( 0 / ). This minimum power is given by
where we have put
Minimum power under linear lower bound on the dose response function
Suppose that the dose response function is bounded below by a linear function:
It is readily seen that for µ ∈ m , power (4.3) is minimized when i = 0 − i and is as large as possible, i.e.,
(The values of i for i > m are irrelevant.) Thus the linear response function is least favorable in this case. Then the power expression becomes
where (z, u) .
Thus (4.7) is minimized when m = k. The final minimum power expression for the linear response function depends on both and ( 0 / ), and is given by
where is as defined in (4.6) and
To evaluate (4.8), the quantity 0 / , which is the inverse of the coefficient of variation for the zero dose, needs to be specified or at least a lower bound on it. (To evaluate (4.5), only the product = ( 0 / ) needs to be specified.) The larger the coefficient of variation, the smaller the power and hence the larger the sample size needed to guarantee a specified power requirement.
Exact discrete optimization problem
The exact optimization problem to be solved is the following: For given k and specified , , ( 0 / ), and 1 − , Minimize N = n 0 + kn subject to (4.5) or (4.8) 1 − .
As noted before, in case of the overall minimum power given by (4.5), one need not specify and ( 0 / ) separately, but only = ( 0 / ). One can use numerical search to solve this optimization problem. However, it can be very time consuming and laborious. Numerical search can be accelerated if we know the optimum value of the ratio r = n 0 /n because then we only need to find the smallest N so that the expression (4.5) or (4.8) is 1 − . This is an easy trial and error exercise because the minimum power is a strictly increasing function of N.
In the next section we find the optimum value of r by solving an approximate continuous problem for the overall minimum power case. (The constrained minimum under a linear response lower bound case could be studied analogously, but it is analytically far more involved.) This continuous approximation also has the advantage that it obviates the need to compute N (and associated n 0 and n) for each specified value of = ( 0 / ); rather it is only necessary to compute a quantity defined in (6.1) and the associated r. We are also able to study the asymptotic behavior of optimum r and show that r → √ k (which is a simple extension of Dunnett's (1955) square root allocation rule) as → ∞. The optimum r found by solving the approximate continuous problem is used as a starting solution for numerical search to find the exact discrete optimum solution to the optimization problem. The corresponding optimum sample sizes are given in Tables 1 and 2 Table 1 Exact (discrete) optimum sample sizes for step response ( = 0.05) 
Approximate continuous optimization problem
To simplify the optimization problem we will assume = ∞ so that the power expression (4.5) for step response reduces to a single integral. Furthermore, we define the quantity
which we treat as a continuous variable along with r. Thus the optimization problem for the step response case can be stated as: For given k and specified , and 1 − , find the smallest value of and the associated value of r so that
here z = t ∞, is the upper critical point of the standard normal distribution. To solve this problem, first fix r and solve (6.2) for c or equivalently . An explicit solution for c can be obtained as follows. Note that the integral in (6.2) equals P {Z 1 c, Z 2 c, . . . , Z k c}, where Z 1 , Z 2 , . . . , Z k have a k-variate standard normal distribution with common correlation 2 = 2 /(r + 2 ). Therefore c is the upper critical point of max 1 i k Z i ; we denote this critical point by z k, 2 , . Dunnetts (1989) program can be used to calculate c = z k, 2 , . Then and the integral in (6.2) is a function of r alone. We denote it by (r), and find the optimum value of r by setting
In Appendix we show, using the same methods as in Bechhofer (1969) , that
where k (x| ) denotes the equicoordinate c.d.f. at point x of a k-variate standard normal distribution with common correlation , and
The solution to the equation (r) = 0 is substituted in = / r + 2 to find a new value of c = z k, 2 , and the process is iterated until convergence is reached. The solutions to the continuous optimization problem are given in Table 3 for the same values of k, , 1 − and as in Tables 1  and 2 . Use of this table is illustrated in Section 7.
It may be noted from Table 3 that as = √ N increases, r approaches √ k. This fact can be shown analytically as follows. As and c → ∞, the first term in the expression for (r) goes to zero faster than the second term because c 2/(1 + 2 ) < c and hence (c 2/(1 + 2 )) > (c). As a result, the second term is the dominant one. Therefore, for large c, the solution to the equation (r) = 0 can be approximated by the solution to the equation where d is given by (6.4). Now for large c and hence large ,
.
Substituting these approximations and = / r + 2 in (6.5), we obtain
the solution to which can be easily checked to be r = √ k. This approximately optimum value of r can be shown to minimize
Putting n 0 = rn and hence n = N/(k + r), we see that, for fixed total sample size N, we need to minimize (k + r)(1 + 2 /r), and the minimizing value is r = √ k.
Example
Suppose that k = 5 doses are to be compared to a zero dose control to find the MAXSD. We do not assume any knowledge of the shape of the response function, and therefore use the step response as the least favorable configuration. The following quantities are specified: = 0.80, = 0.05, = 0.05, 1 − = 0.70 and 0 / = 10, so = (0.05)(10) = 0.50. Then from Table 1, the exact discrete optimum sample sizes are found to be n 0 = 76, n = 53 and N = 341. Here n 0 /n = 1.434, which is not very close to the asymptotically optimal allocation √ k = 1.789. Let us see how these sample sizes compare with those computed from Table 3 We see that these sample sizes are quite close to those obtained from Table 1 , but are slightly smaller. This will generally be the case because the continuous approximation assumes that is known which results in slightly smaller sample sizes. However, the differences are not appreciable especially if N is large. For the linear response case, from Table 2 we find that n 0 = 43, n = 28 and N = 183. Note that the sample sizes are much smaller in this case.
Extensions
In Section 4.2 we assumed that i 0 − i . This linear lower bound implicitly assumes that the doses d i are equispaced. A more general approach might be to incorporate the actual dose values in this lower bound, e.g., assume that
where > 0. We refer to this lower bound as the generalized linear response. Alternatively, one could assume an exponential response lower bound:
where 1. First consider the generalized linear response case. The definitions of m and can be modified in an obvious manner. Then for µ ∈ m , the power is minimized when Power and sample size calculations can be done under these dose response functions by simple modifications in our computer programs. We can provide the programs to anyone interested.
This paper has given a method to compute the sample size for the SD2PC step-down multiple test procedure for finding the maximum safe dose of a compound. The method is based on the least favorable configuration approach. Therefore the resulting sample sizes may be too conservative for practical applications. To resolve this problem, a Bayesian approach can be adopted by putting prior distributions on the unknown parameters. However, this approach faces analytical difficulties as well as the fact that adequate previous knowledge is often lacking to specify full priors. A way out of both these difficulties is to specify a discrete prior distribution on the MAXSD itself, i.e., one could specify prior probabilities p 1 , p 2 , . . . , p k , where p m is the probability that the mth dose is MAXSD (1 m k) . Then instead of using the power expressions (4.5) or (4.7), which use MAXSD = k as the LFC, we will obtain the weighted averages of the corresponding expressions for different values of MAXSD. The simplest prior is the uniform prior: p 1 = p 2 =· · ·=p k = 1/k. We plan to use this uniform prior to compute the required sample sizes and compare them with the sample sizes reported here using the LFC approach. These calculations will be reported in a future paper. Combining the expressions for A, B and C, and substituting them in the last expression for (r) we get the final expression (6.3).
